Glucocerebrosidase (GBA) mutations have been associated with Parkinson’s disease in
numerous studies. However, it is unknown whether the increased risk of Parkinson’s disease in …

Importance Coenzyme Q10 (CoQ10), an antioxidant that supports mitochondrial function, has
been shown in preclinical Parkinson disease (PD) models to reduce the loss of dopamine …

Little is known about the underlying dimensions of impaired recognition of emotional prosody
that is frequently observed in patients with Parkinson's disease (PD). Because patients …

Zydis selegiline dissolves on contact with saliva and undergoes pregastric absorption. This
minimizes first‐pass metabolism and provides high plasma concentrations of selegiline. In …

There is a renewed interest in sexuality in chronic disease states. Whereas there is some
literature on male sexuality in Parkinson's disease (PD), no study has been devoted …

Parkinson’s disease (PD) is a common neurodegenerative disease whose pathological
hallmark is the accumulation of intracellular α-synuclein aggregates in Lewy bodies. Lipid …

Background Biallelic PRKN mutation carriers with Parkinson's disease (PD) typically have
an earlier disease onset, slow disease progression, and, often, different neuropathology …

Cobalamin levels are frequently low in patients with dementia, but it is unclear if they represent
definable deficiency and what the mechanisms are. Therefore, patients being evaluated …

Genome-wide association studies (GWAS) have identified numerous loci associated with
Parkinson’s disease. The specific genes and variants that drive the associations within the vast …

Parkinson’s disease is a progressive, neurodegenerative disorder affecting millions of
people worldwide. Given the aging population, the prevalence of the disease is expected to …